Study paves way for faster, more accurate therapies for hard-to-treat leukemia patients
A new study will enable clinicians to identify patients with aggressive leukemia who will not respond to chemotherapy and those who are most likely to benefit from a new immunotherapy.
Jun 5, 2020
0
113